This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Viera Kasparcova: Innovator in Osteoanabolic Research
Introduction
Viera Kasparcova is a prominent inventor based in Collegeville, PA (US). She has made significant contributions to the field of osteoanabolic research, focusing on the development of compounds that stimulate bone formation. Her work is particularly relevant for the treatment of osteoporosis and other disorders characterized by insufficient bone mass.
Latest Patents
Viera holds 2 patents that showcase her innovative research. The first patent is titled "Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof." This invention provides the rhesus monkey dickkopf-1 (rhDkk-1) and nucleotide sequences encoding it. The isolated rhDkk-1 can be utilized to screen and identify novel osteoanabolic compounds that promote bone formation. This is crucial for treating osteoporosis and similar conditions. The second patent is "Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof." This patent discloses the cynomolgus monkey Dickkopf-4 (cDkk-4) protein and isolated nucleic acid molecules that encode it. The methods described in this patent are aimed at identifying analytes that interfere with the interaction between the cDkk-4 protein and its receptors, which can also aid in treating bone loss disorders.
Career Highlights
Viera is currently employed at Merck & Company, Inc., where she continues her research in the field of osteoanabolic compounds. Her work has been instrumental in advancing the understanding of bone formation and the development of therapeutic strategies for osteoporosis.
Collaborations
Viera collaborates with esteemed colleagues such as Shun-ichi Harada and Helmut Glantschnig. These collaborations enhance the research efforts and contribute to the innovative solutions being developed in the field.
Conclusion
Viera Kasparcova is a dedicated inventor whose work in osteoanabolic research is paving the way for new treatments for osteoporosis and related disorders. Her patents reflect her commitment to advancing medical science and improving patient outcomes.